| Financial Year |
March 31 2023 |
| Monetary Funds |
335,567,918.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
300,000.00 |
| Accounts Receivable |
50,273,453.70 |
| Advances to Suppliers |
6,957,074.74 |
| Other Receivables |
27,292,218.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,995,674.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,261,008.87 |
| Total Current Assets |
436,498,772.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
391,145,137.21 |
| Investment Properties |
-- |
| Fixed Assetes |
168,097,156.96 |
| Under-construction Projects |
210,532,181.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,690,723.85 |
| R&D expenses |
-- |
| Goodwill |
570,127,784.89 |
| Long-Term Deferred and Prepaid Expenses |
61,601.42 |
| Deferred Income Tax Assets |
24,121,059.03 |
| Other Non-Current Assets |
1,359,542.00 |
| Sub-Total of Non-Current Assets |
1,430,903,265.00 |
| Total Assets |
1,867,402,037.41 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
150,481,702.09 |
| Accounts Received In Advance |
364,689.58 |
| Employee Compensation Payable |
30,865,661.23 |
| Taxes Payable |
7,412,709.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,207,078.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,525,515.78 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
228,730,541.37 |
| Long-term Loans |
36,400,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
57,141,053.08 |
| Total Liabilities |
285,871,594.45 |
| Paid-In Capital(Or Share Stock) |
337,941,402.00 |
| Capital Surplus |
392,255,458.77 |
| Surplus Reserve |
91,644,089.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
733,457,138.07 |
| Minority Stockholder's Interest |
26,679,826.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,554,850,616.42 |
| Owner's Equity（Stockholder's Equity） |
1,581,530,442.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,867,402,037.41 |
